Development of a multiplex microsphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens

Journal of Immunological Methods

Volumn 364, Issue 1-2, 2011, Pages 83-93

  Griffin, Shannon M ^a,b   Chen, Ing M ^b   Fout, G Shay ^b   Wade, Timothy J ^c   Egorov, Andrey I ^c  

^a OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Cryptosporidium; Helicobacter pylori; Luminex immunoassay; Noroviruses; Salivary antibody; Toxoplasma gondii; Waterborne

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICROSPHERE;

ACUTE DIARRHEA; ADULT; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CRYPTOSPORIDIUM; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER PYLORI; HUMAN; IMMUNOASSAY; LUMINEX IMMUNOASSAY; NOROVIRUS; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVA LEVEL; SEROCONVERSION; TOXOPLASMA GONDII; VOMITING;

ADULT; ANTIGENS, BACTERIAL; ANTIGENS, PROTOZOAN; ANTIGENS, VIRAL; CALICIVIRIDAE INFECTIONS; CHILD, PRESCHOOL; COMMUNITY HEALTH SERVICES; CROSS REACTIONS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GASTROENTERITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICROSPHERES; NOROVIRUS; PROTEIN BINDING; SALIVA; SEROLOGIC TESTS; TOXOPLASMA; TOXOPLASMOSIS;

CRYPTOSPORIDIUM; HELICOBACTER PYLORI; NOROVIRUS; TOXOPLASMA GONDII;

EID: 78650830000     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.11.005     Document Type: Article

References (51)

1. 13C]urea breath test. Clin. Diagn. Lab. Immunol. 2002, 9:493.
2. Cevallos A.M., Zhang X., Waldor M.K., Jaison S., Zhou X., Tzipori S., Neutra M.R., Ward H.D. Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect. Immun. 2000, 68:4108.
3. Colford J.M., Roy S., Beach M.J., Hightower A., Shaw S.E., Wade T.J. A review of household drinking water intervention trials and an approach to the estimation of endemic waterborne gastroenteritis in the United States. J. Water Health 2006, 4(Suppl 2):71.
4. Colford J.M., Wade T.J., Sandhu S.K., Wright C.C., Lee S., Shaw S., Fox K., Burns S., Benker A., Brookhart M.A., van der Laan M., Levy D.A. A randomized, controlled trial of in-home drinking water intervention to reduce gastrointestinal illness. Am. J. Epidemiol. 2005, 161:472.
5. Cozon G., Biron F., Jeannin M., Cannella D., Revillard J.P. Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. J. Infect. Dis. 1994, 169:696.
6. DeLean A., Munson P.J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 1978, 235:E97.
7. Egorov A.I., Montuori Trimble L.M., Ascolillo L., Ward H.D., Levy D.A., Morris R.D., Naumova E.N., Griffiths J.K. Recent diarrhea is associated with elevated salivary IgG responses to Cryptosporidium in residents of an Eastern Massachusetts community. Infection 2010, 38:117.
8. Erdman D.D., Gary G.W., Anderson L.J. Serum immunoglobulin A response to Norwalk virus infection. J. Clin. Microbiol. 1989, 27:1417.
9. Findlay J.W., Dillard R.F. Appropriate calibration curve fitting in ligand binding assays. AAPS J. 2007, 9:E260.
10. Gammie A., Morris R., Wyn-Jones A.P. Antibodies in crevicular fluid: an epidemiological tool for investigation of waterborne disease. Epidemiol. Infect. 2002, 128:245.
11. Hellard M.E., Sinclair M.I., Forbes A.B., Fairley C.K. A randomized, blinded, controlled trial investigating the gastrointestinal health effects of drinking water quality. Environ. Health Perspect. 2001, 109:773.
12. Jiang X., Matson D.O., Ruiz-Palacios G.M., Hu J., Treanor J., Pickering L.K. Expression, self-assembly, and antigenicity of a Snow Mountain agent-like Calicivirus capsid protein. J. Clin. Microbiol. 1995, 33:1452.
13. Jiang X., Wang M., Graham D.Y., Estes M.K. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 1992, 66:6527.
14. Lee C.K., Weltzin R., Thomas W.D., Kleanthous H., Ermak T.H., Soman G., Hill J.E., Ackerman S.K., Monath T.P. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 1995, 172:161.
15. Liang J.L., Dziuban E.J., Craun G.F., Hill V., Moore M.R., Gelting R.J., Calderon R.L., Beach M.J., Roy S.L., Centers for Disease Control and Prevention (CDC) Surveillance for waterborne disease and outbreaks associated with drinking water and water not intended for drinking - United States, 2003-2004. MMWR Surveill. Summ. 2006, 55:31.
16. Lindesmith L., Moe C., Lependu J., Frelinger J.A., Treanor J., Baric R.S. Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 2005, 79:2900.
17. Lindesmith L., Moe C., Marionneau S., Ruvoen N., Jiang X., Lindblad L., Stewart P., LePendu J., Baric R. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 2003, 9:548.
18. Luzza F., Oderda G., Maletta M., Imeneo M., Mesuraca L., Chioboli E., Lerro P., Guandalini S., Pallone F. Salivary immunoglobulin G assay to diagnose Helicobacter pylori infection in children. J. Clin. Microbiol. 1997, 35:3358.
19. Marchese R.D., Puchalski D., Miller P., Antonello J., Hammond O., Green T., Rubinstein L.J., Caulfield M.J., Sikkema D. Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum. Clin. Vaccine Immunol. 2009, 16:387.
20. Martins T.B., Augustine N.H., Hill H.R. Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to group A streptococci. J. Immunol. Methods 2006, 316:97.
21. McKie A., Vyse A., Maple C. Novel methods for the detection of microbial antibodies in oral fluid. Lancet Infect. Dis. 2002, 2:18.
22. Messner M., Shaw S., Regli S., Rotert K., Blank V., Soller J. An approach for developing a national estimate of waterborne disease due to drinking water and a national estimate model application. J. Water Health 2006, 4(Suppl 2):201.
23. Moe C.L., Sair A., Lindesmith L., Estes M.K., Jaykus L.A. Diagnosis of Norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant Norwalk virus antigen. Clin. Diagn. Lab. Immunol. 2004, 11:1028.
24. Monroe S.S., Stine S.E., Jiang X., Estes M.K., Glass R.I. Detection of antibody to recombinant Norwalk virus antigen in specimens from outbreaks of gastroenteritis. J. Clin. Microbiol. 1993, 31:2866.
25. Morris-Cunnington M.C., Edmunds W.J., Miller E., Brown D.W. A novel method of oral fluid collection to monitor immunity to common viral infections. Epidemiol. Infect. 2004, 132:35.
26. Morris-Cunnington M.C., Edmunds W.J., Miller E., Brown D.W. A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am. J. Epidemiol. 2004, 159:786.
27. Moss D.M., Bennett S.N., Arrowood M.J., Hurd M.R., Lammie P.J., Wahlquist S.P., Addiss D.G. Kinetic and isotypic analysis of specific immunoglobulins from crew members with cryptosporidiosis on a U.S. Coast Guard cutter. J. Eukaryot. Microbiol. 1994, 41:52S.
28. Moss D.M., Bennett S.N., Arrowood M.J., Wahlquist S.P., Lammie P.J. Enzyme-linked immunoelectrotransfer blot analysis of a cryptosporidiosis outbreak on a United States Coast Guard cutter. Am. J. Trop. Med. Hyg. 1998, 58:110.
29. Moss D.M., Chappell C.L., Okhuysen P.C., DuPont H.L., Arrowood M.J., Hightower A.W., Lammie P.J. The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J. Infect. Dis. 1998, 178:827.
30. Moss D.M., Montgomery J.M., Newland S.V., Priest J.W., Lammie P.J. Detection of Cryptosporidium antibodies in sera and oral fluids using multiplex bead assay. J. Parasitol. 2004, 90:397.
31. Nishanian P., Aziz N., Chung J., Detels R., Fahey J.L. Oral fluids as an alternative to serum for measurement of markers of immune activation. Clin. Diagn. Lab. Immunol. 1998, 5:507.
32. Nokes D.J., Enquselassie F., Vyse A., Nigatu W., Cutts F.T., Brown D.W. An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. Trans. R. Soc. Trop. Med. Hyg. 1998, 92:679.
33. Payment P., Richardson L., Siemiatycki J., Dewar R., Edwardes M., Franco E. A randomized trial to evaluate the risk of gastrointestinal disease due to consumption of drinking water meeting current microbiological standards. Am. J. Public Health 1991, 81:703.
34. Payment P., Siemiatycki J., Richardson L., Renaud G., Franco E., Prevost M. A prospective epidemiological study of gastrointestinal health effects due to the consumption of drinking water. Int. J. Environ. Health Res. 1997, 7:5.
35. Plikaytis B.D., Turner S.H., Gheesling L.L., Carlone G.M. Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1991, 29:1439.
36. Preidis G.A., Wang H.-C., Lewis D.E., Castellanos-Gonzalez A., Rogers K.A., Graviss E.A., Ward H.D., White A.C. Seropositive human subjects produce interferon gamma after stimulation with recombinant Cryptosporidium hominis gp15. Am. J. Trop. Med. Hyg. 2007, 77:583.
37. Priest J.W., Bern C., Xiao L., Roberts J.M., Kwon J.P., Lescano A.G., Checkley W., Cabrera L., Moss D.M., Arrowood M.J., Sterling C.R., Gilman R.H., Lammie P.J. Longitudinal analysis of Cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children. Clin. Vaccine Immunol. 2006, 13:123.
38. Priest J.W., Kwon J.P., Moss D.M., Roberts J.M., Arrowood M.J., Dworkin M.S., Juranek D.D., Lammie P.J. Detection by enzyme immunoassay of serum immunoglobulin G antibodies that recognize specific Cryptosporidium parvum antigens. J. Clin. Microbiol. 1999, 37:1385.
39. Priest J.W., Li A., Khan M., Arrowood M.J., Lammie P.J., Ong C.S., Roberts J.M., Isaac-Renton J. Enzyme immunoassay detection of antigen-specific immunoglobulin G antibodies in longitudinal serum samples from patients with cryptosporidiosis. Clin. Diagn. Lab. Immunol. 2001, 8:415.
40. Quoilin S., Hutse V., Vandenberghe H., Claeys F., Verhaegen E., De Cock L., Van Loock F., Top G., Van Damme P., Vranckx R., Van Oyen H. A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium. Eur. J. Epidemiol. 2007, 22:195.
41. Reilly T.G., Poxon V., Sanders D.S., Elliott T.S., Walt R.P. Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests. Gut 1997, 40:454.
42. Reynolds K.A., Mena K.D., Gerba C.P. Risk of waterborne illness via drinking water in the United States. Rev. Environ. Contam. Toxicol. 2008, 192:117.
43. Sandhu S.K., Priest J.W., Lammie P.J., Hubbard A., Colford J.M., Eisenberg J.N. The natural history of antibody responses to Cryptosporidium parasites in men at high risk of HIV infection. J. Infect. Dis. 2006, 194:1428.
44. Stroehle A., Schmid K., Heinzer I., Naguleswaran A., Hemphill A. Performance of a Western immunoblot assay to detect specific anti-Toxoplasma gondii IgG antibodies in human saliva. J. Parasitol. 2005, 91:561.
45. Tan M., Fang P., Chachiyo T., Xia M., Huang P., Fang Z., Jiang W., Jiang X. Noroviral P particle: structure, function and applications in virus-host interaction. Virology 2008, 382:115.
46. Tan M., Jiang X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J. Virol. 2005, 79:14017.
47. USEPA GWR 40 CFR Parts 9, 141, and 142 national primary drinking water regulations: ground water rule; final rule. Federal Register/Vol. 71, No. 216 2006.
48. USEPA LT2 40 CFR Parts 9, 141, and 142 national primary drinking water regulations: long term 2 enhanced surface water treatment rule; final rule. Federal Register/Vol. 71, No. 3 2006.
49. USEPA Estimating the burden of disease associated with outbreaks reported to the U.S. waterborne disease outbreak surveillance system: identifying limitations and improvements. U.S. Environmental Protection Agency, National Center for Environmental Assessment, Cincinnati, OH. EPA/600/R-06/069 2007, http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=156410.
50. Vyse A.J., Cohen B.J., Ramsay M.E. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health 2001, 115:201.
51. 104th Congress, August 6 Safe Drinking Water Act Amendments of 1996. Public Law 104-182 Summary at. http://www.epa.gov/OGWDW/sdwa/summ.html#3D.